Fallaux; Frits J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fallaux; Frits J..The latest application filed is for "stocks of replication-deficient adenovirus".

Company Profile

0.6.6

Fallaux; Frits J. - Be Leiderdorp NL
Fallaux; Frits J. - Leiderdorp NL
Fallaux, Frits J. - Leiderdrop NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer Grant 8,236,293 - Fallaux , et al. August 7, 2	2012-08-07
Stocks of replication-deficient adenovirus App 20090023196 - Fallaux; Frits J. ; et al.	2009-01-22
Packaging systems for human recombinant adenovirus to be used in gene therapy App 20080138901 - Fallaux; Frits J. ; et al.	2008-06-12
Packaging systems for human recombinant adenovirus to be used in gene therapy App 20060246569 - Fallaux; Frits J. ; et al.	2006-11-02
Packaging systems for human recombinant adenovirus to be used in gene therapy Grant 7,105,346 - Fallaux , et al. September 12, 2	2006-09-12
Packaging systems for human recombinant adenovirus to be used in gene therapy Grant 7,052,881 - Fallaux , et al. May 30, 2	2006-05-30
Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer App 20050221492 - Fallaux, Frits J. ; et al.	2005-10-06
Packaging systems for human recombinant adenovirus to be used in gene therapy Grant 6,692,966 - Fallaux , et al. February 17, 2	2004-02-17
Packaging systems for human recombinant adenovirus to be used in gene therapy App 20020187553 - Fallaux, Frits J. ; et al.	2002-12-12
Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer App 20020164802 - Fallaux, Frits J. ; et al.	2002-11-07
Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer Grant 6,395,519 - Fallaux , et al. May 28, 2	2002-05-28
Packaging systems for human recombinant adenovirus to be used in gene therapy Grant 6,265,212 - Fallaux , et al. July 24, 2	2001-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.